Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Toll Biotech Co. Ltd. (beijing)

Clinical trials sponsored by Toll Biotech Co. Ltd. (beijing), explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New pill aims to tame rheumatoid arthritis pain and swelling Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet recruiting 1

New pill aims to tame rheumatoid arthritis pain and swelling

Disease control Recruiting now

This study tests a new oral drug, TollB-001, in 24 adults aged 18-70 with moderate to severe active rheumatoid arthritis who haven't responded well to standard treatments. Participants take either the drug or a placebo once daily for 4 weeks, with a 1-week follow-up. The goal is …

Phase 2 • Sponsor: Toll Biotech Co. Ltd. (Beijing) • Aim: Disease control

Last updated Jun 27, 2026 09:06 UTC